Ad
related to: edwards lifesciences stock price target 2030
Search results
Results From The WOW.Com Content Network
Price Action: EW stock is up 4.21% at $73.15 at last check Wednesday. Read Next: UnitedHealth Group Issued 2025 Guidance Ahead Of Now Stopped Investor Conference
Edwards Lifesciences Corporation (NYSE:EW) shares are trading higher on Thursday. Stifel analyst Rick Wise upgraded Edwards from Hold to Buy, raising the price forecast to $90 from $75. Wise ...
Edwards lifted its 2023 sales forecast to between $5.9 billion and $6.1 billion, from $5.6 billion to $6.0 billion estimated earlier. The new mid-point is slightly higher than analysts' estimates ...
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter . [ 4 ]
Investors continue to be optimistic about Edwards Lifesciences' (EW) performance. For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
The stock of Edwards Lifesciences (NYSE:EW, 30-year Financials) gives every indication of being modestly overvalued, according to GuruFocus Value calculation.
Investors are optimistic about Edwards Lifesciences (EW) on continued strong adoption of the SAPIEN 3 Ultra platform and the PASCAL system.